Výsledky vyhledávání - "Anton P, van de Woestijne"

Akademický článek

Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease.

Autor: Anton P van de Woestijne, Yolanda van der Graaf, Paul I W de Bakker, Folkert W Asselbergs, Wilko Spiering, Frank L J Visseren, SMART Study Group

Publikováno v: PLoS ONE, Vol 9, Iss 6, p e101082 (2014)

Single nucleotide polymorphisms in the APOA5-A4-C3-A1 gene complex are associated with elevated plasma triglycerides and elevated vascular risk in healthy populations. In patients with clinically manifest vascular disease, hypertriglyceridemia and me

Externí odkaz: https://doaj.org/article/d60242af8239433b8265675eec7a3cb6

Zobrazit plný text záznamu

LDL-c-linked SNPs are associated with LDL-c and myocardial infarction despite lipid-lowering therapy in patients with established vascular disease

Autor: Paul I.W. de Bakker, Frank L.J. Visseren, Yolanda van der Graaf, Ale Algra, Folkert W. Asselbergs, Gert J. de Borst, Wilko Spiering, Anton P. van de Woestijne

Publikováno v: European Journal of Clinical Investigation. 44:184-191

Background Several single-nucleotide polymorphisms (SNPs) are associated with both plasma low-density lipoprotein cholesterol (LDL-c) level and coronary artery disease in the general population. It is unclear whether these associations also apply to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69902f02f01d5554b486224774b1c831
https://doi.org/10.1111/eci.12206

Zobrazit plný text záznamu

Plasma triglyceride levels increase the risk for recurrent vascular events independent of LDL-cholesterol or nonHDL-cholesterol

Autor: Anton P, van de Woestijne, Annemarie M J, Wassink, Houshang, Monajemi, An-Ho, Liem, Hendrik M, Nathoe, Yolanda, van der Graaf, Frank L J, Visseren, F L J, Visseren

Publikováno v: International Journal of Cardiology. 167(2):403-408

BackgroundPlasma triglyceride (TG) levels are known to confer an increased risk of vascular disease in healthy populations, but data in high-risk patients are scarce. In this study we evaluated the risk on recurrent vascular events conferred by incre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11f2a0133824a201b48af61445ed6e80

Zobrazit plný text záznamu

Effect of Statin Therapy on Incident Type 2 Diabetes Mellitus in Patients With Clinically Manifest Vascular Disease

Autor: Yolanda van der Graaf, Jan Westerink, Frank L.J. Visseren, Anton P. van de Woestijne, Hendrik M. Nathoe

Publikováno v: American Journal of Cardiology, 115(4), 441. Elsevier Inc.

Several trials and cohort studies have shown an increased incidence of type 2 diabetes mellitus (T2DM) in patients using statins. Whether this only applies to patients at already high risk for the development of T2DM or for all patients is still a ma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe32301e6413557ff72210ebe6c773ed
https://dspace.library.uu.nl/handle/1874/331571

Zobrazit plný text záznamu

Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot study

Autor: Teun P. van Es, J. Wouter Jukema, Erik Bruijns, Henk K. van Halteren, Henk W. O. Roeters van Lennep, Aeilko H. Zwinderman, Job A. J. de Boo, Anton P. van de Woestijne, Arnoud van der Laarse, Anho Liem, Dirk J. van Veldhuisen

Publikováno v: International journal of cardiology, 131(2), 285-287. Elsevier Ireland Ltd
International Journal of Cardiology, 131(2), 285-287. ELSEVIER IRELAND LTD

A pilot study was performed to determine the effect of 40,000 IU Epo on myocardial damage in 51 patients with non-ST segment elevation acute coronary syndrome (non-STE ACS). No significant difference in myocardial damage was found, but an increased s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31e6f8048446cbf527e5cf0ec6aa1707
https://pure.amc.nl/en/publications/effect-of-epo-administration-on-myocardial-infarct-size-in-patients-with-nonste-acute-coronary-syndromes-results-from-a-pilot-study(69c20ea4-33c6-4ae5-bb09-bf374094aada).html

Zobrazit plný text záznamu

Low High-Density Lipoprotein Cholesterol Is Not a Risk Factor for Recurrent Vascular Events in Patients With Vascular Disease on Intensive Lipid-Lowering Medication

Autor: Anton P, van de Woestijne, Yolanda, van der Graaf, An-Ho, Liem, Maarten J M, Cramer, Jan, Westerink, Frank L J, Visseren

Publikováno v: Journal of the American College of Cardiology. (20):1834-1841

Objectives This study sought to evaluate the vascular risk of low high-density lipoprotein-cholesterol (HDL-C) in relation to the use and intensity of lipid-lowering medication in patients with clinically manifest vascular diseases. Background Low le

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba74ab866335b529921d41920e53183e

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání